A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis
NCT06116565
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL:
CM310
Sponsor
Keymed Biosciences Co.Ltd